Oxaliplatin-loaded anti-EGFR immunoliposomes for potential colorectal cancer therapy: comparative preparation strategies and cytotoxicity evaluation

Key Points

• To evaluate the effectiveness of oxaliplatin-loaded anti-EGFR immunoliposomes in colorectal cancer therapy.
• Comparative analysis of different preparation strategies for immunoliposomes containing oxaliplatin and anti-EGFR antibodies.
• Cytotoxicity evaluations in colorectal cancer cells.
• Assessment of the therapeutic potential of the prepared formulations.
• Demonstrated improved cytotoxicity of oxaliplatin-loaded immunoliposomes compared to free drug.
• Showed enhanced targeting to EGFR-positive cancer cells.
• Indicated potential for higher therapeutic efficacy in colorectal cancer treatment.

Abstract